TABLE 5.
KEGG pathway | % relative abundance under indicated grain treatment conditions |
SEM |
P value |
|||||
---|---|---|---|---|---|---|---|---|
No phytase |
Phytase |
|||||||
CON | LA | CON | LA | Phytase | LA | Phytase × LA | ||
Amino acid metabolism | 32.71 | 35.49 | 27.73 | 28.47 | 2.036 | 0.007 | 0.396 | 0.621 |
Carbohydrate metabolism | 13.76 a | 11.47 b | 13.11 ab | 12.63 b | 0.435 | 0.557 | 0.004 | 0.048 |
Translation | 8.16 bc | 6.48 c | 8.60 b | 10.20 a | 0.729 | 0.009 | 0.960 | 0.035 |
Membrane transport | 5.80 | 5.21 | 6.73 | 6.84 | 0.457 | 0.010 | 0.609 | 0.457 |
Metabolism of cofactors and vitamins | 4.39 b | 6.44 a | 3.97 b | 4.33 b | 0.319 | < 0.01 | < 0.01 | 0.014 |
Folding, sorting, and degradation | 3.96 | 3.49 | 4.83 | 4.58 | 0.395 | 0.020 | 0.373 | 0.778 |
Energy metabolism | 2.37 | 1.81 | 2.39 | 2.25 | 0.109 | 0.046 | 0.003 | 0.063 |
Signal transduction | 1.28 | 1.22 | 1.40 | 1.48 | 0.068 | 0.012 | 0.921 | 0.318 |
Glycan biosynthesis and metabolism | 0.88 b | 0.86 b | 1.00 b | 1.32 a | 0.076 | < 0.01 | 0.055 | 0.037 |
Lipid metabolism | 0.98 | 1.10 | 0.91 | 0.91 | 0.041 | 0.005 | 0.220 | 0.172 |
Cell growth and death | 0.76 | 0.51 | 0.87 | 0.60 | 0.108 | 0.381 | 0.026 | 0.935 |
Metabolism of terpenoids and polyketides | 0.67 | 0.52 | 0.80 | 0.75 | 0.073 | 0.020 | 0.167 | 0.494 |
Cell motility | 0.74 | 0.60 | 0.72 | 0.66 | 0.026 | 0.388 | 0.001 | 0.112 |
Membrane transport | 6.33 | 5.75 | 7.33 | 7.45 | 0.472 | 0.009 | 0.630 | 0.463 |
Transport and catabolism | 0.68 | 0.84 | 0.56 | 0.24 | 0.162 | 0.037 | 0.623 | 0.155 |
Xenobiotics biodegradation and metabolism | 0.64 | 0.59 | 0.70 | 0.73 | 0.032 | 0.005 | 0.737 | 0.236 |
Cell communication | 0.35 | 0.33 | 0.40 | 0.40 | 0.020 | 0.005 | 0.710 | 0.473 |
Values are presented as least-square means ± SEM (n = 8 pigs per dietary treatment). Different lowercase letters (a, b, and c) in cell entries within a row indicate a significant difference (P ≤ 0.05). KEGG, Kyoto Encyclopedia of Genes and Genomes; Con, control; LA, lactic acid-treated cereals. Only KO level 2 pathways whose results were significantly different (P ≤ 0.05) or tended to be different (P ≤ 0.10) among treatments are presented.